I’m not sure. Unlike the US we don’t have a large stockpile of vaccines we don’t intend to use (the US has at least 50 million doses of AstraZeneca that it’s just sitting on).
We could probably spare a million/week of domestically produced AstraZeneca though without a meaningful drop off in our own vaccination program.
That’s encouraging. 
We need, according to my calculations, 18 million doses just to clear up the backlogs. 
Maybe one of Cummings most altrustic acts ever in service to his nation (But I am prejudiced and dont know all he does obviously). A very good thread indeed.
They are really trying every tricks in the book.
141.181 jabs yesterday
Got my Moderna jab today, arm is fucking sore and was absolutely soaked queuing up.
Apart from the arm, head feels weird, not really a headache and not sure how to explain it but It feels a bit meh.
Anyone else had Moderna and what side effects did they have?
My father (almost 90 yr old) received his Moderna 1st dose a while ago, he told me that he had a sore arm for a couple of days, but that was pretty much it.
Sinovac is now reporting much better efficacy rates than in the trial studies. This is good news meaning more options. But whether it is really so or now a PR overdrive by the Chinese makers and its backers (we all know who they are) is up to anyone’s guess.
@gasband what vaccine are you using in Singapore?
Pfizer and Moderna for now. I am taking my dose of Pfizer on 4th June and the 2nd does 6 weeks later. We already have stocks of Sinovac delivered to us a couple of months ago, hilariously by the Chinese Makers because of advanced purchase orders even if our health authority had not approved it usage in Singapore.
However, we are now seeing news in the media of how countries like Indonesia and Brazil etc are reporting way better efficacy compared to its trials of just above 50%. So the feel on the ground are the chinese are on overdrive to push for higher usage of its vaccines by more countries. And honestly, if Singapore approves it, it does send a stamp of endorsement at least in the region. But I feel like Singapore, having more responsible governance might wait for bigger and credible countries in terms of healthcare to have studies and data before approving it, at least that is what I hope.
Do you have enough dosages? We ran out of stocks within two months.
It seems we do have enough stocks. We were moving along pretty well on the standard 21/28 days gap for the 2 doses but because of the recent spikes and the new variants found in Singapore, the government decided to more the gaps to 6-8 weeks so that all eligible groups of people can be injected with at least one dose by end of July. This also includes the new age group of 12-15. So far it seems assured we have at least dosages for the 1st dose for the entire population. Right now we have around close to 40% with one dose at least and 20% with both doses and by end of July, we probably have 100% eligible population (except those who choose not to take them or those with serious conditions) on at least one dose and closer to 40-50% with both doses. And the government still hope to complete full vaccine cycle by end of the year or even earlier.
This is quite important. AZ was supposed to be available in Thailand from Jan/ Feb this year but got delayed following the debacle in UK/EU and also through their own government’s mishandling. They got Sinovac but no-one wanted to take it, and instead people are waiting until June for the vaccinations to roll out properly with the AZ vaccine now being made in Thailand.
Hopefully that won’t be an issue for too long. Production of vaccines is increasing. Increased availability should mean less stockpiling, further increasing availability to where they are needed and Improved development should reduce wastage and widen availability.
I’ve seen big question marks over Sinovac due to the data coming out of Brazil. It’s a fair bit less effective than AstraZeneca on those measures.
From a standing start the UK’s now producing about 3 million doses per week of AstraZeneca domestically. I anticipate that in the 14 other countries where it’s being made around the world they’ll be seeing similarly improved production volumes.